M Shi Selected Research

M Shi Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 08/2001
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2001
7	Neoplasm Metastasis (Metastasis) 03/2021 - 07/2007
4	Ischemia 07/2015 - 08/2000
3	Lymphoma (Lymphomas) 10/2021 - 01/2021
3	Nasopharyngeal Carcinoma 01/2020 - 01/2019
3	Arthrogryposis renal dysfunction cholestasis syndrome 05/2019 - 03/2006
3	Myocardial Ischemia (Ischemic Heart Diseases) 07/2015 - 08/2000
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2020
2	Extranodal NK-T-Cell Lymphoma 10/2021 - 05/2021
2	Fibrosis (Cirrhosis) 10/2021 - 01/2016
2	Liver Neoplasms (Liver Cancer) 07/2021 - 11/2019
2	Disease Progression 06/2019 - 11/2014
2	Body Weight (Weight, Body) 04/2018 - 11/2014
2	Hypertension (High Blood Pressure) 01/2017 - 03/2001
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 06/2013
2	Breast Neoplasms (Breast Cancer) 01/2016 - 11/2013
2	Reperfusion Injury 07/2015 - 01/2014
2	Carcinogenesis 02/2014 - 01/2011
2	Necrosis 01/2014 - 11/2008
2	Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris) 06/2013 - 03/2011
2	Atopic Dermatitis (Atopic Eczema) 06/2013 - 03/2011
2	Heart Failure 01/2011 - 02/2000
2	Wounds and Injuries (Trauma) 05/2010 - 07/2006
2	Infections 02/2007 - 08/2000
1	Inflammation (Inflammations) 10/2021
1	Gastro-enteropancreatic neuroendocrine tumor 08/2021
1	Hepatitis B 07/2021
1	Communicable Diseases (Infectious Diseases) 07/2021
1	COVID-19 05/2021
1	Critical Illness (Critically Ill) 05/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2021
1	Liver Diseases (Liver Disease) 02/2021
1	End Stage Liver Disease 02/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2019
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 06/2019
1	Thymoma (Thymic Carcinoma) 05/2018

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2000
4	Messenger RNA (mRNA)IBA 01/2017 - 08/2000
3	CytokinesIBA 01/2021 - 11/2013
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
2	Phosphotransferases (Kinase)IBA 10/2021 - 06/2013
2	CreatinineIBA 10/2021 - 11/2014
2	Tyrosine Kinase InhibitorsIBA 07/2021 - 05/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2014
2	NF-kappa B (NF-kB)IBA 01/2021 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2019
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2020 - 06/2019
2	NitrogenIBA 04/2018 - 11/2014
2	Urea (Carbamide)FDA LinkGeneric 04/2018 - 11/2014
2	CatecholaminesIBA 01/2016 - 08/2000
2	MelatoninIBA 07/2015 - 01/2014
2	LipopolysaccharidesIBA 01/2014 - 11/2008
2	InterleukinsIBA 06/2013 - 07/2007
2	Filaggrin ProteinsIBA 06/2013 - 03/2011
2	EnzymesIBA 03/2011 - 03/2001
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2008 - 07/2007
1	trastuzumab deruxtecanIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	disitamab vedotinIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	oxymatrineIBA 10/2021
1	Biological ProductsIBA 08/2021
1	Antiviral Agents (Antivirals)IBA 07/2021
1	DNA (Deoxyribonucleic Acid)IBA 07/2021
1	Death Domain ReceptorsIBA 07/2021
1	Thyroid HormonesIBA 05/2021
1	Asparaginase (Elspar)FDA Link 01/2021
1	NivolumabIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	SolventsIBA 01/2021
1	Estrogen ReceptorsIBA 01/2020
1	CateninsIBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 06/2019
1	P-2 (P 2)IBA 05/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	nimotuzumabIBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2018

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2022 - 04/2006
7	Therapeutics 07/2021 - 08/2000
5	Radiotherapy 10/2021 - 01/2019
2	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2021 - 11/2019
2	Immunotherapy 01/2021 - 07/2007
1	Hyperthermic Intraperitoneal Chemotherapy 03/2021
1	Liver Transplantation 02/2021
1	Adjuvant Chemotherapy 05/2020
1	Laparotomy 05/2020
1	Gastrectomy 05/2020
1	Aftercare (After-Treatment) 06/2019